CNL Healthcare Properties, Inc.
CHTHReal Estate · Real Estate Investment Trusts · MD · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $338.7M | $314.6M | $295.8M | $265.3M | $280.9M | $288.3M |
| Operating income | $30.9M | $13.7M | $8.9M | −$177,000 | $21.7M | $41.6M |
| Net income | −$14.5M | −$25.7M | −$1.5M | −$22.9M | $3.9M | $351.5M |
| Total assets | $1.32B | $1.37B | $1.44B | $1.44B | $1.50B | $1.62B |
| Total liabilities | $607.6M | $621.5M | $647.0M | $625.8M | $634.7M | $715.4M |
| Equity | $711.8M | $743.6M | $789.8M | $809.0M | $867.5M | $899.2M |
| EPS (diluted) | $-0.08 | $-0.15 | $-0.01 | — | — | — |
| Shares out. | 175.3M | 174.0M | 174.0M | 174.0M | 174.0M | 174.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- 9.1%
- Net margin
- −4.3%
- Return on equity
- −2.0%
- Return on assets
- −1.1%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 46.1%
- Debt / equity
- 0.85×
- Book value / share
- $4.06
- Revenue growth (YoY)
- 7.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Accruals / assets
- −4.1%clean
- Piotroski F-Score
- 5/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 5 good- Reported a net loss
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Mar 13, 2026 | 1,066 | 1000.0 | 0.0% |
| Feb 27, 2026 | 1,066 | 1.0 | 0.0% |
| Feb 13, 2026 | 1,066 | 1.0 | 0.0% |
| Jan 30, 2026 | 1,066 | 1.0 | 0.0% |
| Jan 15, 2026 | 1,066 | 1.0 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMar 9, 2026
- Shareholder voteMar 6, 2026
- Regulation FD disclosureMar 3, 2026
- Regulation FD disclosure · Other material eventFeb 17, 2026
- Other material eventFeb 13, 2026
- Other material eventJan 14, 2026
- Entered a material agreement · Amended charter or bylaws · Other material eventNov 5, 2025
- Regulation FD disclosureMar 13, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.